Literature DB >> 9850863

Thymocyte selection: not by TCR alone.

D Amsen1, A M Kruisbeek.   

Abstract

During development of T cells in the thymus, T-cell receptor (TCR)-mediated recognition of self-MHC/self-peptide complexes on thymic stroma dictates the developmental fate of immature CD4+CD8+ (double positive) thymocytes. Intriguingly, TCR-generated intracellular signals can elicit two entirely different cellular responses in such thymocytes: apoptosis or further differentiation. The critical issue in understanding end-stage T-cell development is how TCR occupancy can be perceived in such markedly different ways by the TCR. Here, we review the cytoplasmic and nuclear events that result from TCR signaling during thymocyte selection. Studies aimed at distinguishing molecular components involved in positive selection (resulting in signals for further differentiation) and negative selection (resulting in apoptosis) will help solve this fascinating feature of T-lymphocyte biology. We also discuss how non-TCR-derived signaling might serve to fine tune the TCR-driven selection events in thymocytes. Central to this aspect of the conceptual framework needed to explain thymocyte selection is the observation that thymic antigen-presenting cells appear to be specialized in the induction of either positive or negative selection. Finally, we suggest a hypothesis that integrates the facts currently available on developing thymocytes, and which may serve to refine our exploration of unresolved issues in thymocyte selection. This hypothesis expands our focus to include signals from receptors other than TCRs as modulating and amplifying factors in thymocyte signaling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850863     DOI: 10.1111/j.1600-065x.1998.tb01241.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  10 in total

Review 1.  The thymus and negative selection.

Authors:  H Kishimoto; J Sprent
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Functional requirement for class I MHC in CNS development and plasticity.

Authors:  G S Huh; L M Boulanger; H Du; P A Riquelme; T M Brotz; C J Shatz
Journal:  Science       Date:  2000-12-15       Impact factor: 47.728

Review 3.  Review article: thymus organ cultures and T-cell receptor repertoire development.

Authors:  G Anderson; E J Jenkinson
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

Review 4.  Individuality of Ag-selected and preimmune TCR repertoires.

Authors:  J L Maryanski; V Attuil; A Hamrouni; M Mutin; M Rossi; A Aublin; P Bucher
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 5.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

6.  Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice.

Authors:  D Kim; X C Peng; X H Sun
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

Review 7.  Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance.

Authors:  Edmond J Yunis; Joaquin Zuniga; Viviana Romero; Emilio J Yunis
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice.

Authors:  Monica Froicu; Yan Zhu; Margherita T Cantorna
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

9.  In vitro co-culture systems for studying molecular basis of cellular interaction between Aire-expressing medullary thymic epithelial cells and fresh thymocytes.

Authors:  Yoshitaka Yamaguchi; Jun Kudoh; Tetsuhiko Yoshida; Nobuyoshi Shimizu
Journal:  Biol Open       Date:  2014-10-17       Impact factor: 2.422

10.  Type 1 cytokines polarize thymocytes during T cell development in adult thymus organ cultures.

Authors:  Barbara J Whalen; Jan Marounek; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  J Autoimmun       Date:  2003-02       Impact factor: 7.094

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.